Volume 43, Number 5, 200836th annual meeting of the European Radiation Research Society
|Number of page(s)||1|
|Section||Poster Presentation - Radiation Sensitivity|
|Published online||03 September 2008|
Radiosensitization of Toll-like receptor 7 agonists in Caco-2 cells
Dep. of Biomedical Science, Hallym University, 39, Hallymdaehak-gil, 200-702 Chuncheon, Republic of Korea
2 Lab. of modulation of radiobiological responses, Korea Institute of Radiation and Medical Sciences, 215-4, Gongneung-dong, Nowon-Gu, 139-706 Seoul, Republic of Korea
In this present study, we intended to estimate radiosenitization of Toll-like receptor 7 agonists, Imiquimod (IMQ) in Caco-2 cells, adenocarcinoma of the colon. IMQ showed anti-tumoral activity in Caco-2 cells determined by clonogenic assay for 10 days after treatment. IMQ treatment induced NF-kB activation, junctional disruptions, and pro-apoptotic activity in Caco-2 cells, determined by degradation of Ik-B, E-cadherin, and Bcl-xl, respectively. To determine radiosensitization of IMQ in Caco-2 cells, 4 Gy and 8 Gy of irradiation were applied in the presence or absence of IMQ treatment. IMQ enhanced radiosensitivity at 4 Gy of irradiation, determined from clonogenic assay. The molecular mechanisms underlying radiosensitization appears to be similar to molecular alterations involved in anti-tumoral activity. However, irradiation with IMQ treatment showed synergistic effects on downregulation of E-cadherin and Bcl-xl. From these results, we estimated IMQ as an effective radiosensitizer for colon cancer treatment. In vivo experiments are undergoing to confirm radiosensitization of IMQ in xenograft tumor model and syngeneic mouse tumor model.
Key words: Toll-like receptor 7 agonists / Imiquimod / Caco-2 / radiosenitization
© EDP Sciences, 2008
Initial download of the metrics may take a while.